tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JP:4569 Stock Latest News

KYORIN Wins Approval for Faster, More Sensitive GeneSoC FluA/B Influenza Test Kit
Company AnnouncementsKYORIN Wins Approval for Faster, More Sensitive GeneSoC FluA/B Influenza Test Kit
15d ago
4569
KYORIN Pharma Releases Nine-Month Consolidated Results and Outlook
PremiumCompany Announcements
KYORIN Pharma Releases Nine-Month Consolidated Results and Outlook
15d ago
4569
KYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook
PremiumCompany Announcements
KYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook
15d ago
4569
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
PremiumCompany Announcements
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
1M ago
4569
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
PremiumCompany Announcements
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
3M ago
4569
KYORIN Partners with Hinge Bio for SLE Drug Development in Japan
PremiumCompany AnnouncementsKYORIN Partners with Hinge Bio for SLE Drug Development in Japan
5M ago
4569
KYORIN Pharma Announces Phase 3 Study Results for Pulmonary Sarcoidosis Treatment
Premium
Company Announcements
KYORIN Pharma Announces Phase 3 Study Results for Pulmonary Sarcoidosis Treatment
5M ago
4569
KYORIN Pharmaceutical Reports Strong Quarterly Growth Amidst Challenging Full-Year Outlook
Premium
Company Announcements
KYORIN Pharmaceutical Reports Strong Quarterly Growth Amidst Challenging Full-Year Outlook
7M ago
4569
KYORIN Pharmaceutical Announces Dividend Distribution
PremiumCompany Announcements
KYORIN Pharmaceutical Announces Dividend Distribution
9M ago
4569
KYORIN Pharmaceutical Announces Executive Personnel Changes
PremiumCompany Announcements
KYORIN Pharmaceutical Announces Executive Personnel Changes
9M ago
4569
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
PremiumCompany Announcements
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
9M ago
4569
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
PremiumCompany Announcements
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
9M ago
4569
KYORIN Pharmaceutical Reports Strong Financial Growth Amidst Upcoming Challenges
PremiumCompany AnnouncementsKYORIN Pharmaceutical Reports Strong Financial Growth Amidst Upcoming Challenges
9M ago
4569
KYORIN Pharmaceutical Upgrades Earnings Forecasts Following Licensing Deals
Premium
Company Announcements
KYORIN Pharmaceutical Upgrades Earnings Forecasts Following Licensing Deals
10M ago
4569
KYORIN and Novartis Forge Global License Agreement for KRP-M223
Premium
Company Announcements
KYORIN and Novartis Forge Global License Agreement for KRP-M223
12M ago
4569
KYORIN Partners with Hyfe for AI-Powered Chronic Cough Therapy
PremiumCompany Announcements
KYORIN Partners with Hyfe for AI-Powered Chronic Cough Therapy
12M ago
4569
KYORIN Pharmaceutical Secures Option for Novel Post-Viral Hyposmia Treatment
PremiumCompany Announcements
KYORIN Pharmaceutical Secures Option for Novel Post-Viral Hyposmia Treatment
1y ago
4569
KYORIN Pharmaceutical Reports Decline in Nine-Month Financial Performance
PremiumCompany Announcements
KYORIN Pharmaceutical Reports Decline in Nine-Month Financial Performance
1y ago
4569
KYORIN Enters Agreement with BIODOL for Novel Pain Treatment
PremiumCompany Announcements
KYORIN Enters Agreement with BIODOL for Novel Pain Treatment
1y ago
4569
KYORIN Strikes Deal with Bayer for OSA Treatment
PremiumCompany AnnouncementsKYORIN Strikes Deal with Bayer for OSA Treatment
1y ago
4569

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >